Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey.
Ahmadzay ZF, Heberg J, Jørgensen JB, Ørnbjerg LM, Østergaard M, Møller-Bisgaard S, Michelsen B, Loft AG, Jones GT, Hellamand P, Scherer A, Nissen MJ, Pavelka K, Závada J, Laas K, Vorobjov S, Nordström D, Sokka-Isler T, Regierer AC, Reich A, Gudbjornsson B, Thorarinsdottir K, Iannone F, Favalli EG, van de Sande M, Provan SA, Kvien TK, Rodrigues AM, Gonçalves CF, Codreanu C, Mogosan C, Rotar Z, Prikmajer KP, Castrejon I, Otero-Varela L, Di Giuseppe D, Wallman JK, Ciurea A, Möller B, Kenar-Artın G, Yıldırım TD, Macfarlane GJ, Rotariu O, Glintborg B, Hetland ML. Ahmadzay ZF, et al. Among authors: rotar z. Rheumatol Adv Pract. 2024 Nov 5;8(4):rkae135. doi: 10.1093/rap/rkae135. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 39611201 Free PMC article.
Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis.
Pons M, Georgiadis S, Østergaard M, Ahmadzay ZF, Glintborg B, Heberg J, Christensen SN, Rasmussen S, Loft AG, Castrejón I, Sánchez-Alonso F, Iannone F, Nordström D, Hokkanen AM, Ciurea A, Nissen MJ, Závada J, Pavelka K, Rotar Z, Pirkmajer KP, Michelsen B, Mielnik P, Bernardes M, Khmelinskii N, Laas K, Vorobjov S, Codreanu C, Macfarlane GJ, Jones GT, Gudbjornsson B, Palsson O, Wallman JK, Horst-Bruinsma IV, Onen F, Hetland ML, Ørnbjerg LM. Pons M, et al. Among authors: rotar z. Joint Bone Spine. 2024 Nov 26:105824. doi: 10.1016/j.jbspin.2024.105824. Online ahead of print. Joint Bone Spine. 2024. PMID: 39608666 Free article.
Impact of patient characteristics on ASDAS disease activity state cut-offs in axial spondyloarthritis: results from nine European rheumatology registries.
Ørnbjerg LM, Georgiadis S, Kvien TK, Michelsen B, Rasmussen S, Pavelka K, Zavada J, Loft AG, Kenar G, Solmaz D, Glintborg B, Rodrigues A, Santos MJ, Di Guiseppe D, Wallman JK, Ciurea A, Nissen MJ, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Gudbjornsson B, Palsson O, Hetland ML, Østergaard M. Ørnbjerg LM, et al. Among authors: rotar z. RMD Open. 2024 Nov 2;10(4):e004644. doi: 10.1136/rmdopen-2024-004644. RMD Open. 2024. PMID: 39489531 Free PMC article.
Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study.
Christiansen SN, Horskjær Rasmussen S, Ostergaard M, Pons M, Michelsen B, Pavelka K, Codreanu C, Ciurea A, Glintborg B, Santos MJ, Sari I, Rotar Z, Gudbjornsson B, Macfarlane GJ, Relas H, Iannone F, Laas K, Wallman JK, van de Sande M, Provan SA, Castrejon I, Zavada J, Mogosan C, Nissen MJ, Loft AG, Barcelos A, Erez Y, Pirkmajer KP, Grondal G, Jones GT, Hokkanen AM, Chimenti MS, Vorobjov S, Di Giuseppe D, Kvien TK, Otero-Varela L, van der Horst-Bruinsma I, Hetland ML, Ørnbjerg LM. Christiansen SN, et al. Among authors: rotar z. RMD Open. 2024 Jul 24;10(3):e004166. doi: 10.1136/rmdopen-2024-004166. RMD Open. 2024. PMID: 39053949 Free PMC article.
Establishment of ELISA-comparable moderate and high thresholds for anticardiolipin and anti-β2 glycoprotein I chemiluminescent immunoassays according to the 2023 ACR/EULAR APS classification criteria and evaluation of their diagnostic performance.
Žigon P, Boštic N, Ambrožič A, Rotar Ž, Blokar E, Ogrič M, Čučnik S. Žigon P, et al. Among authors: rotar z. Clin Chem Lab Med. 2024 Jul 24;63(1):164-176. doi: 10.1515/cclm-2024-0570. Print 2025 Jan 29. Clin Chem Lab Med. 2024. PMID: 39044613 Free article.
Sex differences in patient-reported outcomes and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors.
Hellamand P, van de Sande MGH, Nurmohamed MT, van Vollenhoven RF, Hollick RJ, Rotariu O, Rotar Z, Pirkmajer KP, Nordström D, Hokkanen AM, Michelsen B, Kvien TK, Glintborg B, Hetland ML, Østergaard M, Loft AG, Pavelka K, Zavada J, Castrejon I, Otero-Varela L, Gudbjornsson B, Palsson O, Olofsson T, Wallman JK, Ciurea A, Nissen MJ, Yildirim TD, Onen F, Codreanu C, Mogosan C, Santos MJ, Vieira-Sousa E, Iannone F, Frediani B, Ørnbjerg LM, Twisk JWR, van der Horst-Bruinsma IE. Hellamand P, et al. Among authors: rotar z. Rheumatology (Oxford). 2024 Jul 23:keae370. doi: 10.1093/rheumatology/keae370. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 39041780
Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries.
Linde L, Georgiadis S, Ørnbjerg LM, Rasmussen SH, Michelsen B, Askling J, Di Giuseppe D, Wallman JK, Závada J, Pavelka K, Bernardes M, Matos CO, Glintborg B, Loft AG, Nordström D, Kuusalo L, Möller B, Nissen MJ, Codreanu C, Mogosan C, Gudbjornsson B, Love TJ, Akleylek C, Iannone F, Kvien TK, Rotar Z, Castrejon I, Macfarlane GJ, Hetland ML, Østergaard M. Linde L, et al. Among authors: rotar z. Arthritis Care Res (Hoboken). 2024 Nov;76(11):1558-1565. doi: 10.1002/acr.25396. Epub 2024 Aug 19. Arthritis Care Res (Hoboken). 2024. PMID: 38926900
Molecular maps of synovial cells in inflammatory arthritis using an optimized synovial tissue dissociation protocol.
Edalat SG, Gerber R, Houtman M, Lückgen J, Teixeira RL, Palacios Cisneros MDP, Pfanner T, Kuret T, Ižanc N, Micheroli R, Polido-Pereira J, Saraiva F, Lingam S, Burki K, Burja B, Pauli C, Rotar Ž, Tomšič M, Čučnik S, Fonseca JE, Distler O, Calado Â, Romão VC, Ospelt C, Sodin-Semrl S, Robinson MD, Frank Bertoncelj M. Edalat SG, et al. Among authors: rotar z. iScience. 2024 Apr 10;27(6):109707. doi: 10.1016/j.isci.2024.109707. eCollection 2024 Jun 21. iScience. 2024. PMID: 38832018 Free PMC article.
Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment response.
Mathew AJ, Hetland ML, Pedersen MP, Rasmussen SH, Glintborg B, Loft AG, Nissen MJ, Möller B, Rodrigues AM, Santos FP, Rotar Z, Tomšič M, Relas H, Peltomaa R, Gudbjornsson B, Löve TJ, Kocaer SB, Koken Avsar A, Midtbøll Ørnbjerg L, Østergaard M. Mathew AJ, et al. Among authors: rotar z. Scand J Rheumatol. 2024 Jul;53(4):237-247. doi: 10.1080/03009742.2024.2336743. Epub 2024 May 21. Scand J Rheumatol. 2024. PMID: 38771017 Free article.
Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?
Georgiadis S, Ørnbjerg LM, Michelsen B, Kvien TK, Di Giuseppe D, Wallman JK, Závada J, Provan SA, Kristianslund EK, Rodrigues AM, Santos MJ, Rotar Ž, Pirkmajer KP, Nordström D, Macfarlane GJ, Jones GT, van der Horst-Bruinsma I, Hellamand P, Østergaard M, Hetland ML. Georgiadis S, et al. Among authors: rotar z. J Rheumatol. 2024 Jul 1;51(7):673-677. doi: 10.3899/jrheum.2023-1217. J Rheumatol. 2024. PMID: 38621792 Free article.
104 results